{
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "document": {
    "pdf_name": "Liu_et_al.__2024_",
    "source_pdf": "data/clinical_files/Liu et al. (2024).pdf",
    "total_pages": 13,
    "total_blocks": 146,
    "total_characters": 36717
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 3,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "In this randomized trial (Clinical trials gov: NCT03722589), sera pre- and post vaccination with quadrivalent inactivated egg based (IIV4), cell culture based (ccIIV4), and recombinant (RIV4) influenza",
      "relevance_explanation": "This quote explicitly states that the randomized trial evaluated quadrivalent recombinant influenza vaccine (RIV4, which is Flublok) alongside quadrivalent inactivated egg-based (IIV4) and cell culture-based (ccIIV4) vaccines, confirming that Flublok (quadrivalent) was evaluated in the pivotal trial."
    },
    {
      "id": 2,
      "quote": "Enrolled and Randomized n=723 vaccine Allocation Flu zone IIV4 n=122 18-44 years: n=57 45-64 years: n=65 Completed day 0 (n=110) 1 month (n=110) and 6 months (n=101) visit Fluarix IIV4 n=120 18-44 years: n=55 45-64 years: n=65 Completed day 0 (n=120) 1 month (n=118) and 6 months (n=107) visit re-enrolled in Year 2 and new enrollees randomized n=684 (139*) ccIIV4 in Year 1 n=214 RIV4 in Year 1 n=152",
      "relevance_explanation": "This quote provides the actual allocation of participants to the Fluarix IIV4 (quadrivalent standard-dose vaccine) and RIV4 (Flublok quadrivalent), showing that both vaccines were directly compared in the pivotal trial."
    },
    {
      "id": 3,
      "quote": "Abbreviations: IIV4: Inactivated influenza vaccine (Fluzone or Fluarix\u00ae Quadrivalent; ccIIV4: Cell culture based IIV ... RIV4: recombinant hemagglutinin influenza vaccine (Flublok\u00ae Quadrivalent.",
      "relevance_explanation": "This quote clarifies that Fluarix\u00ae Quadrivalent is the standard-dose comparator and Flublok\u00ae Quadrivalent is the recombinant vaccine (RIV4), confirming the identity of the vaccines compared in the trial."
    }
  ],
  "model_used": "gpt-4.1"
}